MBAI Secures 1st International Adopter of MedMatrix Yesterday, MedBright AI Investments Inc. (Ticker: MBAI.c or MBAIF for US investors) shared that Rejuvenation Medical Group is the inaugural international adopter of its AI-powered data and analytics platform, MedMatrix. This collaboration underscores the tangible impact of MedMatrix in refining clinic operations and advancing patient care.
Rejuvenation Medical Group, a well-regarded dermatology entity in Canada has chosen to integrate MedMatrix across its 9 clinics spanning 3 provinces. The group, known for its comprehensive medical, surgical, cosmetic, and laser treatments, serves a patient base exceeding 750,000 annually.
MedMatrix, harnessing AI's capabilities, evaluates critical aspects of healthcare facilities, including patient needs, resource matching, revenue cycle management, patient demographics, facility geography, and competition.
Through this strategic partnership, MedMatrix aims to optimize Rejuvenation Medical Group's clinic operations, enhancing efficiency and patient outcomes. Overall, MedMatrix is estimated to increase revenue by 10% at no additional cost to clinics.
Dr. Paul Kuzel, Medical Director and Dermatologist at Rejuvenation Medical Group, acknowledged the need for AI to improve the patient experience and clinic revenue.
Trevor Vieweg, the new CEO of MedBright, expressed excitement about the collaboration, highlighting its strategic significance and the opportunity to demonstrate MedMatrix's value in a large-scale operation like Rejuvenation's.
Full news here: https://www.globenewswire.com/news-release/2024/01/09/2806135/0/en/MedBright-AI-Announces-Rejuvenation-Medical-Group-a-Large-Canadian-Clinic-Group-as-First-International-Customer-for-MedMatrix-the-AI-Driven-Data-and-Analytics-Platform.html
Posted on behalf of Medbright AI Investments Inc